Lunai Bioworks Inc. LNAI
1.93
(0.01)
(0.52%)
as of 25 Sep
- Market cap
- $8.8M
- P/E
- 0.0×
Follow LNAI
Growth Flags
show if company had growth for consecutive years
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (325.46%) | (366.44%) | (308.01%) | (321.81%) |
+8 more TTM periods Free account |
|
| (201.09%) | (212.74%) | (203.39%) | (207.76%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
825.67% | 644.58% | 692.65% | 641.66% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.69) | (1.97) | (2.56) | (3.82) | |
Free Cash Flow |
(5.29) | (5.79) | (7.21) | (7.87) | |
Capital Expenditures |
(0.03) | (0.07) | — | — | |
Piotroski F-Score |
2.00 | — | — | — | |
| Other line items | |||||
Cash ROIC |
82.19% | 43.80% | 58.05% | 37.73% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.04 | 0.05 | 0.06 | 0.04 | |
Depreciation/Fixed assets |
9,460.75 | 9,246.65 | 13,646.76 | 463.79 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.68) | (1.95) | (2.56) | (3.82) | |
Capex per Share |
(0.01) | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates